Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/22/2866762/0/en/Lexeo-Therapeutics-Announces-License-Agreement-to-Accelerate-Development-of-LX2006-for-the-Treatment-of-Friedreich-Ataxia-Cardiomyopathy.html
https://www.pharmaceutical-technology.com/news/lexeo-wins-fast-track-designation-for-friedreichs-ataxia-gene-therapy/#:~:text=Clinical%2Dstage%20genetic%20medicine%20company,Friedreich's%20ataxia%20(FA)%20cardiomyopathy.
https://www.globenewswire.com/news-release/2024/04/16/2863488/0/en/Lexeo-Therapeutics-Granted-FDA-Fast-Track-Designation-for-LX2006-an-AAV-Based-Gene-Therapy-Candidate-for-the-Treatment-of-Friedreich-s-Ataxia-Cardiomyopathy.html
https://www.globenewswire.com//news-release/2024/03/13/2845857/0/en/Lexeo-Therapeutics-Announces-Closing-of-Oversubscribed-95-0-Million-Equity-Financing.html
https://www.globenewswire.com//news-release/2024/03/11/2843677/0/en/Lexeo-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Operational-Highlights.html
https://www.globenewswire.com//news-release/2024/03/11/2843669/0/en/Lexeo-Therapeutics-Announces-Oversubscribed-95-0-Million-Equity-Financing.html
https://www.globenewswire.com//news-release/2024/02/05/2823389/0/en/Lexeo-Therapeutics-Strengthens-Clinical-Development-Leadership-with-New-Executive-Appointments.html
https://www.globenewswire.com//news-release/2024/01/03/2803167/0/en/Lexeo-Therapeutics-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/12/18/2797672/0/en/Lexeo-Therapeutics-Granted-FDA-Fast-Track-Designation-and-Orphan-Drug-Designation-for-LX2020-an-AAV-Based-Gene-Therapy-Candidate-for-PKP2-Arrhythmogenic-Cardiomyopathy-ACM.html
https://www.globenewswire.com//news-release/2023/12/11/2793716/0/en/Lexeo-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Operational-Highlights.html